Edward Cha
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions
- Colorectal Cancer Treatments and Studies
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
Papers in
- Oncology 44
- Cancer Immunotherapy and Biomarkers 35
- Colorectal Cancer Treatments and Studies 11
- CAR-T cell therapy research 8
- Pancreatic and Hepatic Oncology Research 5
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Lawrence Fong (8 shared papers)Christian Schindler (1 shared paper)Christopher Y. Park (1 shared paper)Mark Klinger (3 shared papers)Craig Cummings (3 shared papers)Yafei Hou (3 shared papers)Antoni Ribas (3 shared papers)Malek Faham (3 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Annals of Oncology (7 papers)Cancer Research (5 papers)The Lancet Oncology (3 papers)ESMO Open (2 papers)
- Partner nations
- United StatesSouth KoreaChina
In The Last Decade
Edward Cha
53 papers receiving 1.7k citations
Edward Cha's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 1.3k
- Immunology 776
- Cancer Research 156
- Pulmonary and Respiratory Medicine 275
- Hepatology 65
Countries citing papers authored by Edward Cha
This map shows the geographic impact of Edward Cha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Cha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Cha more than expected).
Fields of papers citing papers by Edward Cha
This network shows the impact of papers produced by Edward Cha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Cha. The network helps show where Edward Cha may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Cha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 308 | |
| 2 | 2014 | 291 | |
| 3 | 2019 | 175 | |
| 4 | 2016 | 126 | |
| 5 | 2008 | 51 | |
| 6 | 2012 | 41 | |
| 7 | 2017 | 41 | |
| 8 | 2015 | 40 | |
| 9 | 2011 | 40 | |
| 10 | 2023 | 37 | |
| 11 | 2016 | 37 | |
| 12 | 2024 | 35 | |
| 13 | 2018 | 34 | |
| 14 | 2012 | 33 | |
| 15 | 2020 | 33 | |
| 16 | 2015 | 29 | |
| 17 | 2015 | 28 | |
| 18 | 2016 | 26 | |
| 19 | Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study Hit paper breakdown → | 2025 | 26 |
| 20 | 2017 | 23 |
About Edward Cha
Edward Cha is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 56 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (35 papers), Colorectal Cancer Treatments and Studies (11 papers), Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (8 papers), Melanoma and MAPK Pathways (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Advanced Breast Cancer Therapies (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (776 citations), Cancer Research (156 citations), Pulmonary and Respiratory Medicine (275 citations) and Hepatology (65 citations). Edward Cha has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Lawrence Fong, Christian Schindler, Christopher Y. Park, Mark Klinger, Craig Cummings, Yafei Hou, Antoni Ribas, Malek Faham, Jeffrey J. Wallin and Jeffrey R. Infante. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, The Lancet Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.